• Regeneron Pharmaceuticals average pre-tax profit margin for 2023 was 35.2%, a 23.43% increase from 2022.
• Regeneron Pharmaceuticals average pre-tax profit margin for 2022 was 45.97%, a 17.76% decline from 2021.
• Regeneron Pharmaceuticals average pre-tax profit margin for 2021 was 55.9%, a 32.31% decline from 2020.

Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.